NCT00611741View on ClinicalTrials.gov

The Effect of Plasma Osmolality on Brain Glutamate

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2012

Conditions
Schizophrenia
Interventions
DRUG

furosemide, Na supplements

furosemide 20 mg, Na supplements 8g in divided doses/day for 5 days

Trial Locations (1)

06519

34 Park Street, CMHC, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT00611741 - The Effect of Plasma Osmolality on Brain Glutamate | Biotech Hunter | Biotech Hunter